Yuhang Wang
Research Subjects
Yuhang Wang has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
Jin Cai
Department of Pediatrics, Affiliated Hospital of Nantong University
2 shared publicationsShuang Shi
Department of Pediatrics, Affiliated Hospital of Nantong University
2 shared publications
Latest Publications
- Open Access
- 3 June 2026
- Published by Taylor & Francis in Annals of Human Biology
- Vol. 53 (1) , 2661592
Body composition phenotyping of obesity in children aged 6–18 years: multi-strategy clustering and interpretable machine learning
Body composition heterogeneity in childhood obesity is not fully captured by BMI, motivating operational phenotyping using non-invasive measures. To identify body composition-based phenotypes of obesity in children aged 6-18 years using complementary clustering approaches and characterise their discriminative structure through interpretable machine learning. We enrolled 78 obese children (6-18 years) from a single-centre outpatient clinic in a cross-sectional design. Thirteen BIA-derived indices were Z-standardised and analysed using parallel unsupervised strategies (PCA-K-means, HCPC, UMAP-DBSCAN). Cluster quality, stability, and agreement were evaluated by mean silhouette, Jaccard bootstrap (100 resamples), and adjusted Rand index (ARI). Separability was assessed with a random forest classifier using five-fold cross-validation (out-of-fold accuracy; macro/micro AUC), with SHAP for interpretability. Four phenotypes were consistently supported: low-fat/high-muscle, balanced, high-fat/low-muscle, and mixed high-fat/high-muscle. Cross-validated performance was 85.9% accuracy, macro AUC 0.953, and micro AUC 0.965. Structural metrics were silhouette 0.41 and ARI 0.94, with cluster-wise Jaccard 0.789/0.812/0.835/0.858 (range 0.78-0.86). SHAP prioritised fat mass and BMI; BIA-derived basal metabolic indices contributed as device-estimated outputs, while lean mass and skeletal muscle mass showed opposing contributions. This exploratory, single-centre framework is hypothesis-generating and requires external validation with outcome-linked markers and imaging before any clinical applicability is considered.
- 3 June 2026
- Published by Taylor & Francis in Annals of Human Biology
- Vol. 53 (1) , 2661592
Open AccessBody composition phenotyping of obesity in children aged 6–18 years: multi-strategy clustering and interpretable machine learning
Body composition heterogeneity in childhood obesity is not fully captured by BMI, motivating operational phenotyping using non-invasive measures. To identify body composition-based phenotypes of obesity in children aged 6-18 years using complementary clustering approaches and characterise their discriminative structure through interpretable machine learning. We enrolled 78 obese children (6-18 years) from a single-centre outpatient clinic in a cross-sectional design. Thirteen BIA-derived indices were Z-standardised and analysed using parallel unsupervised strategies (PCA-K-means, HCPC, UMAP-DBSCAN). Cluster quality, stability, and agreement were evaluated by mean silhouette, Jaccard bootstrap (100 resamples), and adjusted Rand index (ARI). Separability was assessed with a random forest classifier using five-fold cross-validation (out-of-fold accuracy; macro/micro AUC), with SHAP for interpretability. Four phenotypes were consistently supported: low-fat/high-muscle, balanced, high-fat/low-muscle, and mixed high-fat/high-muscle. Cross-validated performance was 85.9% accuracy, macro AUC 0.953, and micro AUC 0.965. Structural metrics were silhouette 0.41 and ARI 0.94, with cluster-wise Jaccard 0.789/0.812/0.835/0.858 (range 0.78-0.86). SHAP prioritised fat mass and BMI; BIA-derived basal metabolic indices contributed as device-estimated outputs, while lean mass and skeletal muscle mass showed opposing contributions. This exploratory, single-centre framework is hypothesis-generating and requires external validation with outcome-linked markers and imaging before any clinical applicability is considered.
- 22 October 2025
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 40 (2) , e10157
Lipidomic Profiling Reveals Phenotype‐Specific Metabolic Signatures in Obese and Hyperuricemic Children
Objective: This study aims to investigate the phenotype‐specific alterations in lipid metabolism among children with obesity, hyperuricemia, and their co‐occurrence and to explore the potential associations between lipidomic profiles and clinical indicators. Methods: A nontargeted lipidomic analysis was conducted on serum samples from 100 children aged 6–18 years, categorized into control, hyperuricemia, obesity, and combined phenotype groups based on serum uric acid levels and body mass index. Metabolic network reconstruction, pathway enrichment, and correlation analyses were performed to delineate the relationships between lipid metabolic changes and clinical features. Results: The obesity group was characterized by a marked upregulation of triacylglycerols (TG). In the hyperuricemia group, membrane lipids such as phosphatidylcholine (PC) and lysophosphatidylcholine (LPC) were predominantly downregulated, whereas phosphatidylinositol (PI) showed heterogeneous alterations. The combined phenotype exhibited more extensive disruptions across multiple metabolic pathways. Correlation analysis revealed a consistent inverse relationship between TG and glomerular filtration rate (GFR), a strong association between ceramides (Cer) and insulin metabolism, and a distinctive positive correlation between LPC and aspartate aminotransferase (AST) in the hyperuricemia group. Carnitines (CAR) showed bidirectional associations with kidney function–related parameters. Conclusion: Lipid metabolism displays phenotype‐specific regulatory patterns across distinct clinical presentations, with differential pathway involvement and functional enrichment. Key lipid species such as TG, PC, and Cer may serve as potential subtype biomarkers or therapeutic targets, offering novel insights into the early identification and precision management of metabolic disturbances in children.
- 22 October 2025
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 40 (2) , e10157
Lipidomic Profiling Reveals Phenotype‐Specific Metabolic Signatures in Obese and Hyperuricemic Children
Objective: This study aims to investigate the phenotype‐specific alterations in lipid metabolism among children with obesity, hyperuricemia, and their co‐occurrence and to explore the potential associations between lipidomic profiles and clinical indicators. Methods: A nontargeted lipidomic analysis was conducted on serum samples from 100 children aged 6–18 years, categorized into control, hyperuricemia, obesity, and combined phenotype groups based on serum uric acid levels and body mass index. Metabolic network reconstruction, pathway enrichment, and correlation analyses were performed to delineate the relationships between lipid metabolic changes and clinical features. Results: The obesity group was characterized by a marked upregulation of triacylglycerols (TG). In the hyperuricemia group, membrane lipids such as phosphatidylcholine (PC) and lysophosphatidylcholine (LPC) were predominantly downregulated, whereas phosphatidylinositol (PI) showed heterogeneous alterations. The combined phenotype exhibited more extensive disruptions across multiple metabolic pathways. Correlation analysis revealed a consistent inverse relationship between TG and glomerular filtration rate (GFR), a strong association between ceramides (Cer) and insulin metabolism, and a distinctive positive correlation between LPC and aspartate aminotransferase (AST) in the hyperuricemia group. Carnitines (CAR) showed bidirectional associations with kidney function–related parameters. Conclusion: Lipid metabolism displays phenotype‐specific regulatory patterns across distinct clinical presentations, with differential pathway involvement and functional enrichment. Key lipid species such as TG, PC, and Cer may serve as potential subtype biomarkers or therapeutic targets, offering novel insights into the early identification and precision management of metabolic disturbances in children.